Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New York Senator Kirsten Gillibrand Urges Citizens to Help Passing the James Zadroga 9/11 Health and Compensation Reauthorization Act, Parker Waichman LLP Comments
  • USA - English


News provided by

Parker Waichman LLP

Jul 02, 2015, 19:00 ET

Share this article

Share toX

Share this article

Share toX

Port Washington, NY (PRWEB) July 02, 2015 -- Parker Waichman LLP, a national law firm that has spent many years fighting to ensure that the heroes of the 9/11 terrorist attacks are never forgotten comments on Senator Gillibrand's (New York-Democrat) appearance July 1, 2015, on Jon Stewart's "The Daily Show." Senator Gillibrand is the Senate sponsor of the James Zadroga 9/11 Health and Compensation Reauthorization Act" (S.928/HR.1786) and her appearance took place on the fourth anniversary of the Act's passage.

Parker Waichman points out that the Zadroga Act is comprised of two programs: The World Trade Center (WTC) Health Program and the September 11th Victim Compensation Fund (VCF). Both programs require full funding and, not a five-year extension, but a permanent extension. The WTC Health Program provides medical treatment and monitoring, while the September 11th VCF provides compensation.

Senator Gillibrand discussed finding common ground with her peers on "issues of conscience, like the 9/11 health bill where you have to stand up and do the right thing." The senator noted that one of the police officers in attendance with her that night, had also stated at a recent hearing that, "If we don't pass this, people will die." Since 9/11, said Senator Gillibrand, "1700 people have died and we have nearly 4,000 with horrible cancers." She also noted that, "More cops have died since 9/11 than 9/11 itself."

Parker Waichman comments that renewing the Zadroga Act may save the lives of many 9/11 first responders and survivors. "These responders selflessly answered the call for help; they and their families deserve Zadroga benefits," said Gary Falkowitz, Managing Attorney at Parker Waichman.

Parker Waichman has also long noted that many of the cancers and other illnesses being seen in the responders and survivors of the 9/11 attacks are not always immediately visible or diagnosable. "It is crucial that the Act be extended to ensure that those who were injured are assured of continued benefits and care in future years when other diseases may become evident," noted Matthew McCauley, Senior Litigation Counsel at Parker Waichman.

Senator Gillibrand pointed out, regarding 9/11 responders having to seek help from Congress, "Why would you be asking men and women who answered the call of duty how they're going to pay for their health care. It's outrageous. But they ask these men and women, who many gave their lives, many are still giving their lives, because they answered the call of duty." Stewart agreed, noting that, "This one, honestly is the most galling example of a legislature removed from the purpose of their job and from the patriot-patriotism flag that they wave so heartedly when it serves their needs."

Parker Waichman actively worked toward the 2010 passage of the Zadroga Act, including taking part in grass roots and lobbying efforts and trips to the nation's capital led by Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman, often, along with the firm's clients—other responders and survivors.

Mr. McCauley, Mr. Falkowitz, and Parker Waichman continue to support the Zadroga Act and the efforts to extend the Act's timeline and its scope. In fact, the firm was also involved in the newly released "Take Action" tool that enables injured and ill 9/11 responders and survivors, as well as supporters of the Act, to review their Congresspersons' activities concerning the upcoming expiration of the James Zadroga Act. Parker Waichman assisted with the research on, and creation of, the Tool, which may be accessed at: http://www.renew911health.org/take-action/take-action-contact-your-members-of-congress/.

"These individuals sacrificed their health and well-being on and following the events of 9/11, and now they are suffering because of it," said Mr. McCauley. "We are thrilled to see Senator Gillibrand and Jon Stewart spreading the word, increasing public awareness, and continuing to provide information on the ongoing activities and efforts toward extension of this critical Act."

In closing, Senator Gillibrand urged citizens to "call your Congress members. Call your senator. Please call them. Frankly, the only time anything ever works in Washington is when regular people stand up and demand action, so your voice matters. Please be heard on this issue."

Parker Waichman, which worked, and continues to fight, alongside Ground Zero first responders, survivors, and their advocates, to help ensure passage of the Zadroga Act and its amendments, vows to continue its efforts to safeguard these heroes and ensure that they receive all of the Zadroga Act compensation they deserve. If you or a loved one are eligible for compensation under the Zadroga Act, and would like assistance with your claim, or if you or a loved one have been injured as a result of toxic exposure, please visit Parker Waichman's website or call 1-800-LAW-INFO (1-800-529-4636).

Gary Falkowitz, Parker Waichman LLP, http://yourlawyer.com, +1 (800) 529-4636, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.